Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for VCEL

Stock Name	Vericel Corp Ord
Ticker	VCEL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92346J1088
LEI	54930076YM3PLTDR4B91

Show aggregate VCEL holdings

News associated with VCEL

BTIG Research Downgrades Vericel (NASDAQ:VCEL) to Neutral: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. VCEL has been the subject of a number of other research reports. Stephens reiterated an “overweight” rating and issued a $67.00 price objective on shares of […] - 2025-09-19 02:50:54
Vericel (NASDAQ:VCEL) Shares Gap Down Following Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report)’s share price gapped down prior to trading on Wednesday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The stock had previously closed at $33.23, but opened at $31.85. Vericel shares last traded at $31.15, with a volume of 120,872 shares. A number […] - 2025-09-19 02:18:56
Vericel (NASDAQ:VCEL) Reaches New 52-Week Low on Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The company traded as low as $29.93 and last traded at $30.02, with a volume of 1683483 shares traded. The stock had previously closed […] - 2025-09-18 03:06:42
Vericel Corporation (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Brokerages: Vericel Corporation (NASDAQ:VCEL – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-08-21 04:24:45
Maryland State Retirement & Pension System Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Maryland State Retirement & Pension System trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 13.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,387 shares of the biotechnology company’s stock after selling 2,170 shares during the […] - 2025-08-14 05:17:00
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC grew its stake in Vericel Corporation (NASDAQ:VCEL – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 158,930 shares of the biotechnology company’s stock after acquiring an additional 8,789 shares during the period. Mutual of America Capital Management LLC’s holdings in Vericel were worth […] - 2025-08-08 04:30:54
Geneva Capital Management LLC Has $60.94 Million Stock Holdings in Vericel Corporation (NASDAQ:VCEL): Geneva Capital Management LLC grew its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 24.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,365,744 shares of the biotechnology company’s stock after purchasing an additional 265,956 shares during the quarter. Vericel […] - 2025-08-04 04:28:58
Envestnet Asset Management Inc. Raises Stock Position in Vericel Corporation (NASDAQ:VCEL): Envestnet Asset Management Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 15.6% during the first quarter, Holdings Channel reports. The institutional investor owned 204,510 shares of the biotechnology company’s stock after buying an additional 27,526 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Vericel were worth $9,125,000 as of […] - 2025-07-22 06:48:58
Principal Financial Group Inc. Grows Stake in Vericel Corporation (NASDAQ:VCEL): Principal Financial Group Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 270,154 shares of the biotechnology company’s stock after purchasing an additional 7,222 shares during the period. Principal Financial Group Inc.’s holdings in Vericel were worth $12,054,000 as of its […] - 2025-07-14 04:52:59
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Amalgamated Bank: Amalgamated Bank trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,010 shares of the biotechnology company’s stock after selling 375 shares during the quarter. Amalgamated […] - 2025-07-10 04:40:59
Oregon Public Employees Retirement Fund Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Oregon Public Employees Retirement Fund decreased its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% in the first quarter, Holdings Channel reports. The institutional investor owned 11,293 shares of the biotechnology company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Vericel were worth $504,000 as of […] - 2025-07-08 05:24:54
Allspring Global Investments Holdings LLC Reduces Holdings in Vericel Corporation (NASDAQ:VCEL): Allspring Global Investments Holdings LLC trimmed its position in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 249,441 shares of the biotechnology company’s stock after selling 11,632 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Vericel were worth $10,747,000 […] - 2025-07-04 04:52:25
Vericel Corporation (NASDAQ:VCEL) Given Average Rating of “Buy” by Brokerages: Shares of Vericel Corporation (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on […] - 2025-07-02 05:08:59
Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens: Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […] - 2025-06-18 03:02:52
GAMMA Investing LLC Has $5.76 Million Position in Vericel Co. (NASDAQ:VCEL): GAMMA Investing LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5,916.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 129,175 shares of the biotechnology company’s stock after purchasing an additional 127,028 shares during the quarter. GAMMA Investing LLC’s holdings in Vericel were worth $5,764,000 at the […] - 2025-06-10 04:38:49
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $61.14: Vericel Co. (NASDAQ:VCEL – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year […] - 2025-06-10 03:14:49
Mackenzie Financial Corp Acquires New Stake in Vericel Co. (NASDAQ:VCEL): Mackenzie Financial Corp bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,924 shares of the biotechnology company’s stock, valued at approximately $215,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of VCEL. […] - 2025-06-06 04:50:53
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Deutsche Bank AG: Deutsche Bank AG grew its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 32.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,999 shares of the biotechnology company’s stock after buying an additional 12,890 shares during the quarter. Deutsche Bank AG’s holdings in Vericel were worth $2,910,000 as of its most recent SEC […] - 2025-05-22 04:45:02
BNP Paribas Financial Markets Reduces Stake in Vericel Co. (NASDAQ:VCEL): BNP Paribas Financial Markets lowered its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 35.1% in the 4th quarter, Holdings Channel reports. The fund owned 20,699 shares of the biotechnology company’s stock after selling 11,202 shares during the quarter. BNP Paribas Financial Markets’ holdings in Vericel were worth $1,137,000 as of its most recent […] - 2025-05-21 04:30:48
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. VCEL has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $65.00 target price on shares of Vericel […] - 2025-05-14 02:14:47
The Manufacturers Life Insurance Company Sells 526 Shares of Vericel Co. (NASDAQ:VCEL): The Manufacturers Life Insurance Company lowered its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,593 shares of the biotechnology company’s stock after selling 526 shares during […] - 2025-05-13 05:22:54
Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL): Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […] - 2025-05-09 05:47:10
Vericel Co. (NASDAQ:VCEL) Stock Position Boosted by Mariner LLC: Mariner LLC grew its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,209 shares of the biotechnology company’s stock after acquiring an additional 659 shares during the period. Mariner LLC’s holdings in Vericel were worth $506,000 at the end of […] - 2025-05-02 05:09:04
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL): Renaissance Technologies LLC increased its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,500 shares of the biotechnology company’s stock after purchasing an additional 9,200 shares during the period. Renaissance Technologies LLC’s […] - 2025-04-21 04:46:48
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $60.86: Vericel Co. (NASDAQ:VCEL – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the last year is […] - 2025-04-21 02:30:46
Alliancebernstein L.P. Reduces Stake in Vericel Co. (NASDAQ:VCEL): Alliancebernstein L.P. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 54,730 shares of the biotechnology company’s stock after selling 3,160 shares during the quarter. Alliancebernstein L.P.’s holdings in Vericel were worth $3,005,000 as of its most recent filing with […] - 2025-04-16 04:31:00
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.: Sei Investments Co. cut its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 59,945 shares of the biotechnology company’s stock after selling 5,320 shares during the period. Sei Investments Co.’s holdings in Vericel were worth $3,291,000 as of its most recent filing with […] - 2025-04-04 06:28:59
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.: Corebridge Financial Inc. trimmed its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,155 shares of the biotechnology company’s stock after selling 1,682 shares during the quarter. Corebridge Financial Inc.’s holdings in Vericel […] - 2025-04-04 05:41:01
Prudential Financial Inc. Sells 4,199 Shares of Vericel Co. (NASDAQ:VCEL): Prudential Financial Inc. decreased its holdings in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,004 shares of the biotechnology company’s stock after selling 4,199 shares during the period. […] - 2025-04-04 04:31:04
Avantax Advisory Services Inc. Purchases 234 Shares of Vericel Co. (NASDAQ:VCEL): Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,803 shares of the biotechnology company’s stock after acquiring an additional 234 shares during the period. Avantax […] - 2025-03-21 06:47:07

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) VCEL holdings

Date	Number of VCEL Shares Held	Base Market Value of VCEL Shares	Local Market Value of VCEL Shares	Change in VCEL Shares Held	Change in VCEL Base Value	Current Price per VCEL Share Held	Previous Price per VCEL Share Held
2025-12-03 (Wednesday)	35,042	USD 1,310,220	USD 1,310,220	0	USD -9,111	USD 37.39	USD 37.65
2025-12-02 (Tuesday)	35,042	USD 1,319,331	USD 1,319,331	1,245	USD 7,331	USD 37.65	USD 38.82
2025-12-01 (Monday)	33,797	USD 1,312,000	USD 1,312,000	0	USD -48,329	USD 38.82	USD 40.25
2025-11-28 (Friday)	33,797	USD 1,360,329	USD 1,360,329	83	USD -705	USD 40.25	USD 40.37
2025-11-27 (Thursday)	33,714	USD 1,361,034	USD 1,361,034	0	USD 0	USD 40.37	USD 40.37
2025-11-26 (Wednesday)	33,714	USD 1,361,034	USD 1,361,034	249	USD -62,567	USD 40.37	USD 42.54
2025-11-25 (Tuesday)	33,465	USD 1,423,601	USD 1,423,601	415	USD 138,617	USD 42.54	USD 38.88
2025-11-24 (Monday)	33,050	USD 1,284,984	USD 1,284,984	83	USD -19,850	USD 38.88	USD 39.58
2025-11-21 (Friday)	32,967	USD 1,304,834	USD 1,304,834	0	USD 57,033	USD 39.58	USD 37.85
2025-11-20 (Thursday)	32,967	USD 1,247,801	USD 1,247,801	-332	USD -49,195	USD 37.85	USD 38.95
2025-11-19 (Wednesday)	33,299	USD 1,296,996	USD 1,296,996	83	USD 576	USD 38.95	USD 39.03
2025-11-18 (Tuesday)	33,216	USD 1,296,420	USD 1,296,420	498	USD 6,349	USD 39.03	USD 39.43
2025-11-17 (Monday)	32,718	USD 1,290,071	USD 1,290,071	166	USD -7,452	USD 39.43	USD 39.86

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCEL by Blackrock for IE00BDZVHG35

Show aggregate share trades of VCEL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,245 37.650* 44.73
2025-11-28 BUY 83 40.250* 44.78
2025-11-26 BUY 249 40.370* 44.82
2025-11-25 BUY 415 42.540* 44.83
2025-11-24 BUY 83 38.880* 44.87
2025-11-20 SELL -332 37.850* 44.93 Profit of 14,916 on sale
2025-11-19 BUY 83 38.950* 44.96
2025-11-18 BUY 498 39.030* 44.99
2025-11-17 BUY 166 39.430* 45.02
2025-11-14 BUY 83 39.860* 45.05
2025-11-12 BUY 83 40.440* 45.10
2025-11-10 BUY 83 38.990* 45.15
2025-11-06 BUY 83 38.750* 45.22
2025-11-04 BUY 83 36.250* 45.32
2025-10-30 BUY 415 34.530* 45.48
2025-10-29 BUY 166 34.880 36.990 36.779 USD 6,105 45.54
2025-10-22 SELL -332 36.430 36.830 36.790 USD -12,214 45.80 Profit of 2,993 on sale
2025-10-20 BUY 166 36.020 36.500 36.452 USD 6,051 45.92
2025-10-17 BUY 415 35.320 35.320 35.320 USD 14,658 45.98
2025-10-15 BUY 664 33.590 35.050 34.904 USD 23,176 46.05
2025-10-03 BUY 581 32.440 33.240 33.160 USD 19,266 46.20
2025-10-02 BUY 83 31.520 31.580 31.574 USD 2,621 46.29
2025-09-30 BUY 166 31.470 31.980 31.929 USD 5,300 46.47
2025-09-26 BUY 166 30.230 30.440 30.419 USD 5,050 46.67
2025-09-25 BUY 166 29.840 30.000 29.984 USD 4,977 46.77
2025-09-18 BUY 89 31.850 31.970 31.958 USD 2,844 46.86
2025-09-17 BUY 267 30.020 32.800 32.522 USD 8,683 46.97
2025-07-17 SELL -172 36.260 37.760 37.610 USD -6,469 47.28 Profit of 1,663 on sale
2025-07-11 SELL -688 39.930 40.880 40.785 USD -28,060 47.51 Profit of 4,626 on sale
2025-07-02 BUY 4,730 41.460 42.430 42.333 USD 200,235 47.67
2025-06-25 BUY 172 41.880 43.460 43.302 USD 7,448 47.83
2025-06-20 BUY 779 42.020 42.750 42.677 USD 33,245 47.95
2025-06-11 BUY 168 44.180 45.970 45.791 USD 7,693 48.25
2025-06-10 BUY 168 45.700 45.790 45.781 USD 7,691 48.27
2025-06-04 SELL -84 43.170 43.560 43.521 USD -3,656 48.42 Profit of 411 on sale
2025-04-23 BUY 84 40.050 42.020 41.823 USD 3,513 50.72
2025-04-10 SELL -664 41.900 43.020 42.908 USD -28,491 51.69 Profit of 5,830 on sale
2025-04-08 SELL -83 38.600 41.620 41.318 USD -3,429 51.92 Profit of 880 on sale
2025-04-07 SELL -83 39.900 42.580 42.312 USD -3,512 52.06 Profit of 809 on sale
2025-04-04 SELL -420 41.920 43.120 43.000 USD -18,060 52.18 Profit of 3,857 on sale
2025-04-01 BUY 856 43.090 44.970 44.782 USD 38,333 52.39
2025-03-31 SELL -246 44.620 44.700 44.692 USD -10,994 52.48 Profit of 1,916 on sale
2025-03-21 BUY 1,368 46.260 47.440 47.322 USD 64,736 52.95
2025-03-14 SELL -1,248 45.380 47.160 46.982 USD -58,634 53.39 Profit of 7,994 on sale
2025-03-07 SELL -154 49.560 50.360 50.280 USD -7,743 53.84 Profit of 547 on sale
2025-03-04 SELL -77 51.140 52.060 51.968 USD -4,002 53.99 Profit of 156 on sale
2025-02-25 BUY 154 52.520 52.700 52.682 USD 8,113 54.24
2025-02-19 SELL -77 57.780 58.160 58.122 USD -4,475 54.25 Loss of -298 on sale
2025-02-13 BUY 231 56.810 57.260 57.215 USD 13,217 54.02
2025-02-12 BUY 77 56.020 56.720 56.650 USD 4,362 53.98
2025-02-11 BUY 308 57.510 58.470 58.374 USD 17,979 53.91
2024-12-30 SELL -2,939 55.300 56.970 56.803 USD -166,944 51.78 Loss of -14,755 on sale
2024-11-18 SELL -1,275 52.890 53.780 53.691 USD -68,456 45.88 Loss of -9,961 on sale
2024-11-08 SELL -85 54.000 54.470 54.423 USD -4,626 44.58 Loss of -836 on sale
2024-10-21 SELL -86 41.180 42.280 42.170 USD -3,627 0.00 Loss of -3,627 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,245			37.650*		44.73
2025-11-28	BUY	83			40.250*		44.78
2025-11-26	BUY	249			40.370*		44.82
2025-11-25	BUY	415			42.540*		44.83
2025-11-24	BUY	83			38.880*		44.87
2025-11-20	SELL	-332			37.850*		44.93 Profit of 14,916 on sale
2025-11-19	BUY	83			38.950*		44.96
2025-11-18	BUY	498			39.030*		44.99
2025-11-17	BUY	166			39.430*		45.02
2025-11-14	BUY	83			39.860*		45.05
2025-11-12	BUY	83			40.440*		45.10
2025-11-10	BUY	83			38.990*		45.15
2025-11-06	BUY	83			38.750*		45.22
2025-11-04	BUY	83			36.250*		45.32
2025-10-30	BUY	415			34.530*		45.48
2025-10-29	BUY	166	34.880	36.990	36.779	USD 6,105	45.54
2025-10-22	SELL	-332	36.430	36.830	36.790	USD -12,214	45.80 Profit of 2,993 on sale
2025-10-20	BUY	166	36.020	36.500	36.452	USD 6,051	45.92
2025-10-17	BUY	415	35.320	35.320	35.320	USD 14,658	45.98
2025-10-15	BUY	664	33.590	35.050	34.904	USD 23,176	46.05
2025-10-03	BUY	581	32.440	33.240	33.160	USD 19,266	46.20
2025-10-02	BUY	83	31.520	31.580	31.574	USD 2,621	46.29
2025-09-30	BUY	166	31.470	31.980	31.929	USD 5,300	46.47
2025-09-26	BUY	166	30.230	30.440	30.419	USD 5,050	46.67
2025-09-25	BUY	166	29.840	30.000	29.984	USD 4,977	46.77
2025-09-18	BUY	89	31.850	31.970	31.958	USD 2,844	46.86
2025-09-17	BUY	267	30.020	32.800	32.522	USD 8,683	46.97
2025-07-17	SELL	-172	36.260	37.760	37.610	USD -6,469	47.28 Profit of 1,663 on sale
2025-07-11	SELL	-688	39.930	40.880	40.785	USD -28,060	47.51 Profit of 4,626 on sale
2025-07-02	BUY	4,730	41.460	42.430	42.333	USD 200,235	47.67
2025-06-25	BUY	172	41.880	43.460	43.302	USD 7,448	47.83
2025-06-20	BUY	779	42.020	42.750	42.677	USD 33,245	47.95
2025-06-11	BUY	168	44.180	45.970	45.791	USD 7,693	48.25
2025-06-10	BUY	168	45.700	45.790	45.781	USD 7,691	48.27
2025-06-04	SELL	-84	43.170	43.560	43.521	USD -3,656	48.42 Profit of 411 on sale
2025-04-23	BUY	84	40.050	42.020	41.823	USD 3,513	50.72
2025-04-10	SELL	-664	41.900	43.020	42.908	USD -28,491	51.69 Profit of 5,830 on sale
2025-04-08	SELL	-83	38.600	41.620	41.318	USD -3,429	51.92 Profit of 880 on sale
2025-04-07	SELL	-83	39.900	42.580	42.312	USD -3,512	52.06 Profit of 809 on sale
2025-04-04	SELL	-420	41.920	43.120	43.000	USD -18,060	52.18 Profit of 3,857 on sale
2025-04-01	BUY	856	43.090	44.970	44.782	USD 38,333	52.39
2025-03-31	SELL	-246	44.620	44.700	44.692	USD -10,994	52.48 Profit of 1,916 on sale
2025-03-21	BUY	1,368	46.260	47.440	47.322	USD 64,736	52.95
2025-03-14	SELL	-1,248	45.380	47.160	46.982	USD -58,634	53.39 Profit of 7,994 on sale
2025-03-07	SELL	-154	49.560	50.360	50.280	USD -7,743	53.84 Profit of 547 on sale
2025-03-04	SELL	-77	51.140	52.060	51.968	USD -4,002	53.99 Profit of 156 on sale
2025-02-25	BUY	154	52.520	52.700	52.682	USD 8,113	54.24
2025-02-19	SELL	-77	57.780	58.160	58.122	USD -4,475	54.25 Loss of -298 on sale
2025-02-13	BUY	231	56.810	57.260	57.215	USD 13,217	54.02
2025-02-12	BUY	77	56.020	56.720	56.650	USD 4,362	53.98
2025-02-11	BUY	308	57.510	58.470	58.374	USD 17,979	53.91
2024-12-30	SELL	-2,939	55.300	56.970	56.803	USD -166,944	51.78 Loss of -14,755 on sale
2024-11-18	SELL	-1,275	52.890	53.780	53.691	USD -68,456	45.88 Loss of -9,961 on sale
2024-11-08	SELL	-85	54.000	54.470	54.423	USD -4,626	44.58 Loss of -836 on sale
2024-10-21	SELL	-86	41.180	42.280	42.170	USD -3,627	0.00 Loss of -3,627 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCEL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	224,250	38	329,502	68.1%
2025-09-18	210,642	4,505	422,656	49.8%
2025-09-17	498,057	18	848,500	58.7%
2025-09-16	247,690	103	604,158	41.0%
2025-09-15	250,454	2,198	479,717	52.2%
2025-09-12	226,773	0	440,921	51.4%
2025-09-11	434,580	0	1,188,986	36.6%
2025-09-10	217,511	4	507,036	42.9%
2025-09-09	154,922	1,002	432,147	35.8%
2025-09-08	119,006	0	262,990	45.3%
2025-09-05	205,601	0	280,269	73.4%
2025-09-04	194,429	0	640,877	30.3%
2025-09-03	164,172	465	276,644	59.3%
2025-09-02	115,485	0	201,163	57.4%
2025-08-29	79,439	0	137,361	57.8%
2025-08-28	73,132	0	128,831	56.8%
2025-08-27	224,056	330	450,386	49.7%
2025-08-26	220,373	0	479,253	46.0%
2025-08-25	109,655	0	154,175	71.1%
2025-08-22	231,253	0	366,466	63.1%
2025-08-21	270,342	34,260	440,518	61.4%
2025-08-20	61,162	800	88,729	68.9%
2025-08-19	55,652	350	83,440	66.7%
2025-08-18	223,281	0	397,650	56.2%
2025-08-15	152,782	0	279,452	54.7%
2025-08-14	121,231	43	191,225	63.4%
2025-08-13	155,539	0	317,598	49.0%
2025-08-12	99,112	6,742	139,272	71.2%
2025-08-11	127,401	0	226,595	56.2%
2025-08-08	108,400	0	153,589	70.6%
2025-08-07	158,721	777	213,186	74.5%
2025-08-06	144,941	169	222,689	65.1%
2025-08-05	113,364	0	155,460	72.9%
2025-08-04	202,114	0	265,406	76.2%
2025-08-01	209,380	4,620	311,185	67.3%
2025-07-31	458,933	6,157	947,634	48.4%
2025-07-30	201,101	400	266,955	75.3%
2025-07-29	156,116	34	217,866	71.7%
2025-07-28	126,810	33	181,312	69.9%
2025-07-25	66,015	0	116,396	56.7%
2025-07-24	98,110	197	186,190	52.7%
2025-07-23	190,556	0	299,773	63.6%
2025-07-22	94,561	2,782	216,240	43.7%
2025-07-21	98,734	0	243,030	40.6%
2025-07-18	90,833	60	240,256	37.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE